ClinicalTrials.govpublic full text
Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study
multiple myeloma, high risk smoldering multiple myeloma, ixazomib (mln9708), dexamethasone, 15-294, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 859344
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.